Pluristem Issued U.S. Patent 'Adherent Cells From Placenta Tissue and Use Thereof in Therapy'

By: via Benzinga
Pluristem Therapeutics Inc. (Nasdaq: PSTI) today announced that the U.S. Patent and Trademark Office has issued to the Company patent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.